Short answer
Stryker Corporation (SYK) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Stryker reported second-quarter 2026 operating results on July 30, 2026.
Stryker Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Stryker reported second-quarter 2026 operating results on July 30, 2026
- Detailed financial results and management commentary are contained in Exhibit 99.1
- Disclosure furnished under Item 2.02, limiting its Section 18 liability and incorporation into other filings
Item EX-99.1 · Exhibit EX-99.1
- Q2 net sales $6.6B, up 9.4%; organic growth 9.0%, indicating broad volume-driven demand
- Adjusted operating margin 27.4%, up 170 bps; adjusted EPS $3.69, up 17.9%
- MedSurg and Neurotechnology growth 9.2% organically, outperforming Orthopaedics at 8.6%
- Cyber-incident recovery progressing, with management citing regained momentum entering the second half
- 2026 guidance narrowed to 8.3%-9.3% organic sales growth and $14.95-$15.10 adjusted EPS
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Stryker Corporation 8-K filings
Get the next SYK 8-K as it lands
Follow SYK for push alerts, or ask the research agent what this filing means.